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A B S T R A C T   
Whereas left atrial (LA) enlargement is an independent predictor for adverse cardiovascular events and all-cause 
mortality, this is regarded a physiological adaption of exercise. Paradoxically, LA size in athletes may overlap the 
enlargement observed in patients with cardiac pathology. Current knowledge is mainly derived from studies of 
athletes, and little is known about cardiac adaptations to physical activity (PA) in the general population. We 
explored the association between objectively measured PA and LA volume index (LAVi), and between LAVi 
enlargement and indices of diastolic dysfunction stratified by PA-level. 
Our study included 1573 participants from the population-based Tromsø Study (2015–16). PA was assessed 
with an ActiGraph wGT3X-BT accelerometer. Echocardiography was performed according to current guidelines. 
The associations between PA and LAVi, and between LAVi enlargement and indices of diastolic dysfunction were 
estimated by univariable and multivariable linear regression analyses, adjusted for sex, age, and cardiovascular 
risk factors. 
Our multiple adjusted analyses showed significant linear associations between PA and LAVi in ages < 70 years, 
and between PA and LAVi in participants with normal diastolic function. No associations were seen in ages ≥ 70 
years or for participants with abnormal diastolic function. In those 40–54 years, the most active participants had 
larger LAVi (4.45 mL/m2, p = 0.016) than the least active. LAVi enlargement was only associated with indices of 
diastolic dysfunction in the most inactive participants. 
In conclusion, higher levels of PA associate with greater LAVi in participants < 70 years with normal diastolic 
function. LAVi enlargement is only associated with diastolic dysfunction in the most inactive participants.   
1. Introduction 
Increasing age is associated with adverse structural and functional 
changes in the heart, such as left atrial (LA) enlargement (Obas and 
Vasan, 2018). LA enlargement is an independent predictor for adverse 
cardiovascular disease (CVD) (Tiwari et al., 2015) and all-cause mor-
tality (Stylidis et al., 2019). Furthermore, LA enlargement is a marker of 
the severity and chronicity of left ventricular (LV) diastolic dysfunction 
(Lang et al., 2015), and an important prevention target due to increased 
risk for heart failure (HF) and CVD events (Gajardo and Llancaqueo, 
2019). 
Health authorities recommend physical activity (PA) for health 
promotion and disease prevention, such as CVD and all-cause mortality 
(Piepoli et al., 2016; Bull et al., 2020; The 2018 Physical Activity 
Guidelines Advisory Committee, 2018), and improved diastolic and 
systolic function (Hegde et al., 2016). However, little is known about 
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cardiac adaptations to PA in the general adult and elderly population 
(Joseph et al., 2019); current knowledge is mainly derived from studies 
of athletes (Hegde et al., 2016). Furthermore, the associations between 
PA and health outcomes are primarily based on studies using self- 
reported PA (The 2018 Physical Activity Guidelines Advisory Commit-
tee, 2018), which are prone to recall and social desirability biases 
(Prince et al., 2008). 
Exercise-induced cardiac remodelling is considered a benign physi-
ological adaption of athletic training, characterized by chamber en-
largements and increased LV wall thickness (D’Ascenzi et al., 2020). 
Furthermore, a meta-analysis comprising over 7000 elite athletes, re-
ported that athletes had 30% greater LA size compared with sedentary 
controls, when correcting for body surface area (Iskandar et al., 2015). 
Paradoxically, LA enlargement in athletes may overlap the LA dilation 
observed in patients with cardiac pathology, and thus represent a 
diagnostic challenge for clinicians (D’Ascenzi et al., 2018). The need for 
future research to investigate the possibility of increased risk associated 
with high amounts of PA is highlighted (The 2018 Physical Activity 
Guidelines Advisory Committee, 2018), as the upper and lower limits of 
PA to exert a beneficial effect is unknown (Piepoli et al., 2016). 
We aimed to provide new knowledge on cardiac adaptations to PA in 
the general adult and elderly population. Our main objectives were to: a) 
explore the association between objectively measured PA and LA size, 
and b) investigate if LA enlargement is adversely associated with indices 
of diastolic dysfunction when correcting for PA. We hypothesized that 
LA size is associated with PA, and that LA enlargement is not adversely 
associated with indices of diastolic dysfunction in the most active 
participants. 
2. Methods 
2.1. Study population 
The Tromsø Study (Jacobsen et al., 2012) is a single center 
population-based cohort study with seven repeated health surveys of the 
population of the Tromsø municipality, Northern Norway. This cross- 
sectional study includes participants from the 7th survey (2015–16) 
(The Tromsø Study, 2016). All inhabitants ≥ 40 years were invited (n =
32591), with 21,083 men and women participating (65% attendance). 
The participants completed questionnaires and underwent biological 
sampling and clinical examinations. Of these, a sample of 8346 partic-
ipants (randomly assigned or attendees of dual-energy x-ray absorpti-
ometry, echocardiography and eye examination at the 6th survey in 
2007–08) participated in a second visit with extended examinations. 
Among these, 6125 participants provided valid data on accelerometry, 
and 2340 participants had valid echocardiographic data. In total, 1651 
participants had valid data on both echocardiography and accel-
erometery. Due to missing data for one or more covariates, 78 partici-
pants were excluded (height n = 2, systolic blood pressure n = 5, 
diabetes n = 44, smoking n = 17, low-density lipoprotein (LDL) 
cholesterol n = 10), leaving an analytical sample of 1573 participants 
(Table 1). 
The present study was approved by the Regional Committee for 
Medical and Health Research Ethics (2017/1973/REK Nord) and carried 
out in accordance with the Declaration of Helsinki. All participants 
signed written informed consent. 
2.2. Assessment of PA 
PA was assessed objectively in three axes with an accelerometer 
(wGT3X-BT, ActiGraph LLC, Pensacola, FL, USA) placed on the partici-
pants’ right hip. The participants were instructed to perform their daily 
activities as usual, and to wear the accelerometer day and night for eight 
consecutive days, except during water activities. Valid measurements 
were defined as wear-time ≥ 10 h/day for ≥ 4 days. Details of the data 
collection and accelerometer data processing procedures are described 
elsewhere (Sagelv et al., 2019). The accelerations are expressed as 
average counts per minute (CPM), and categorized into moderate-to- 
vigorous PA (MVPA, ≥ 2690 CPM) based on validated cut-points 
(Sasaki et al., 2011). Steps were collected from acceleration on the 
vertical axis. The participants’ CPM were furthermore divided into PA- 
quartiles, with the least active quartile 1 as reference: quartile 1 =≤406 
CPM, quartile 2 = 407–514 CPM, quartile 3 = 515–634 CPM and 
quartile 4 = ≥635 CPM. 
2.3. Data collection 
Data from questionnaires, physical examinations and blood samples 
were used for the following covariates: Smoking (currently/previously, 
never), diabetes (currently/previously, no), use of antihypertensives 
(currently, previously/never), myocardial infarction (previously, no) 
and stroke (previously, no). Body mass index (BMI) was calculated as 
weight (kg) divided by height squared (m2). Blood pressure was recor-
ded three times with 1 min interval after 2 min rest, using an automatic 
Table 1 
Descriptive characteristics of the study population by age groups: The Tromsø 
Study 2015–16.  
Variable 40–54 years 
(n ¼ 305) 
55–69 years 
(n ¼ 729) 
≥70 years (n 
¼ 539) 
Age, years 47.7 (4.4) 63.3 (4.0) 75.7 (4.0) 
Gender, % (n) female 59.3 (181) 53.1 (387) 45.8 (247) 
Body mass index, kg/m2 27.1 (5.0) 27.0 (4.2) 27.2 (4.1) 
Systolic blood pressure, 
mmHg 
121.9 (16.4) 132.9 (18.8) 143.2 (20.7) 
Diastolic blood pressure, 
mmHg 
74.3 (10.3) 76.0 (9.9) 74.3 (9.9) 
LDL cholesterol, mmol/L 3.5 (0.9) 3.7 (1.0) 3.3 (1.1) 
Smoking, % (n)a 55.7 (170) 64.1 (467) 61.4 (331) 
Hypertension, untreated, % 
(n)b 
17.0 (52) 36.1 (263) 54.2 (292) 
Hypertension, controlled, 
% (n)c 
4.9 (15) 15.9 (115) 22.6 (121) 
Myocardial infarction, % 
(n) 
0 (0) 4.8 (35) 13.3 (70) 
Stroke, % (n) 0 (0) 2.6 (19) 6.6 (35) 
Diabetes, % (n) 3.6 (11) 5.9 (43) 10.2 (55) 
Echocardiography    
LA volume index, mL/m2 32.0 (9.0) 32.6 (10.9) 37.8 (14.7) 
LV mass index male, g/h2.7 41.7 (11.3) 46.3 (13.9) 51.8 (18.9) 
LV mass index female, g/ 
h2.7 
36.2 (9.8) 41.2 (12.5) 47.5 (18.6) 
e’ velocity, lateral, cm/s 12.7 (3.0) 9.6 (2.4) 8.0 (2.4) 
e’ velocity, septal, cm/s 9.8 (2.2) 7.4 (2.1) 6.2 (2.1) 
E/e’ratio 7.5 (2.0) 8.9 (3.4) 11.0 (6.7) 
Tricuspid regurgitation 
velocity, m/s 
1.4 (0.7) 1.5 (0.8) 1.7 (0.8) 
Ejection fraction < 40%, % 5.8 (15) 6.9 (44) 12.4 (57) 
Physical activity    
Mean wear time all valid 
days, hours 
118.0 (15.4) 118.4 (16.1) 113.0 (17.4) 
Total PA, CPM 611.6 (174.1) 550.9 (170.4) 449.9 (159.6) 
PA-quartile 1, % (n) 9.5 (29) 18.9 (138) 41.9 (226) 
PA-quartile 2, % (n) 23.9 (73) 25.4 (185) 25.2 (136) 
PA-quartile 3, % (n) 25.2 (77) 27.7 (202) 21.0 (113) 
PA-quartile 4, % (n) 41.3 (126) 28.0 (204) 11.9 (64) 
MVPA, min/day 53.5 (30.5) 44.5 (29.9) 26.8 (24.9) 






LDL: low-density lipoprotein, LA: left atrium, LV: left ventricle, E/e’ratio: ratio 
of mitral peak velocity of early filling (E) to early diastolic mitral annular ve-
locity (e’), CPM: counts per minute, PA: physical activity, MVPA: moderate-to- 
vigorous physical activity. 
Numbers are mean ± standard deviation or percentage and n. 
a Smoking: current and previous. 
b Hypertension, untreated: systolic blood pressure ≥ 140 mmHg and/or dia-
stolic blood pressure ≥ 90 mmHg and no self-reported use of antihypertensives. 
c Hypertension, controlled: systolic blood pressure < 140 mmHg and diastolic 
blood pressure < 90 mmHg, and self-reported use of antihypertensives. 
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device (Dinamap ProCare 300 monitor, GE Healthcare, Norway), the 
average from reading two and three was used. Blood samples were 
analysed for LDL cholesterol at the Department of Laboratory Medicine, 
University Hospital of North Norway. 
2.4. Cardiac structure and function 
Echocardiography was performed by a qualified sonographer be-
tween August 2015 and October 2016, using a GE Vivid E9 (GE Medical, 
Horten, Norway) ultrasound scanner. Offline image readings and ana-
lyses were performed by co-author M.S. with the commercially available 
EchoPac software (Ver. 113, GE Vingmed Ultrasound AS, Horten, Nor-
way). Echocardiographic assessment was performed with the use of 
standard imaging planes in the left lateral decubitus position according 
to the joint American and European guidelines (Lang et al., 2015; 
Nagueh et al., 2016). The echocardiographic assessment was performed 
on 3–5 consecutive cardiac cycles, and the average was used in the 
analysis. 
LA volume was measured at the end of the LV systole and calculated 
using the Simpson’s biplane method from the apical four- and two 
chamber views. The LA volume was indexed to body surface area (LAVi) 
using the Mosteller formula (Mosteller, 1987). Mitral annular e’ velocity 
was measured in apical four-chamber view with pulsed-wave tissue 
Doppler in both lateral and septal basal regions. Average E/e’ratio was 
calculated by peak E-wave velocity divided by annular average e’ ve-
locity both collected in apical four-chamber view. Tricuspid regurgita-
tion velocity (TRV) was measured as peak modal velocity from the right 
ventricle to the right atrium during systole, using apical four-chamber 
view with continuous wave Doppler. LAVi, E/e’ratio, e’ velocity and 
TRV were used to consider diastolic function according to the guidelines 
(Nagueh et al., 2016). In our analysis, diastolic function was considered 
as: a) normal if < 50% of the variables were above the cut-offs, or b) 
abnormal if ≥ 50% of the variables were above the cut-offs. 
LV myocardial mass was calculated according to the cube formula 
(Lang et al., 2015), and further indexed to height by raising height to the 
power of 2.7 (Williams et al., 2018). LV volume was calculated at the 
end of diastole, using the Simpson’s biplane method from the apical 
four- and two chamber views. Ejection fraction was calculated from the 
end-diastolic and end-systolic estimates of LV volume, and individuals 
with ejection fraction < 40% were considered as having HF (Ponikowski 
et al., 2016). Severity of the mitral and aortic stenosis was assessed by 
measuring mitral valve area and aortic flow mean pressure gradient, 
respectively. Mitral regurgitation severity grade was obtained by qual-
itative estimation of the color Doppler flow jet area. Pressure half-time 
of regurgitant aortic flow as well as central jet width were used for 
assessment of the severity of the aortic regurgitation (Zoghbi et al., 
2017). 
An intra- and inter-observer study was performed on the echocar-
diography data (Stylidis et al., 2020). Intra-class correlation coefficients 
on Doppler indices and linear measurements were 0.90–0.99 in the 
intra-observer study, and 0.84–0.98 in the inter-observer study. 
2.5. Statistical methods 
The associations between the PA measures and LAVi, and between 
LAVi enlargement and indices of diastolic function were estimated by 
univariable and multivariable linear regression analyses. The associa-
tions are presented as unstandardized coefficients with 95% confidence 
intervals (CI). Coefficients for MVPA are presented for every 10 min 
increase per day (MVPA per 10 min/day), and steps are presented for 
every 1000 steps per day increase (steps per 1000/day). The multivar-
iable model (Model 2) was adjusted for sex, age, and CVD risk factors 
(BMI, systolic blood pressure, diabetes, smoking, and LDL cholesterol). 
In a sub-analysis, we used an extended multivariable model (Model 3), 
which was adjusted for Model 2 in addition to myocardial infarction, HF, 
mitral regurgitation, mitral stenosis, aortic regurgitation, and aortic 
valve flow mean pressure gradient. 
In the multivariable model with the PA measures as exposure and 
LAVi as outcome, we first included stepwise interactions between 
PA*age, PA*sex, PA*hypertension, PA*BMI, PA* diastolic function, 
PA*CVD, and PA*LV mass index. We then included only the significant 
interaction terms (PA*age, and PA*diastolic function) in the multivari-
able model. We stratified our main analyses by three age groups and 
diastolic function, as the interactions between PA*age, and PA*diastolic 
function were significant. All statistical analyses were performed using 
SPSS version 25 (SPSS Inc., IL, USA), with the alpha level set to 0.05. 
3. Results 
Descriptive characteristics from questionnaires, biological sam-
plings, clinical examinations, and assessment of PA are given for the 
participants stratified by age groups in Table 1. The mean age was 64.5 
(SD 10.7, range 40–84) years and mean BMI was 27.1 (SD 4.3) kg/m2. 
The proportion of men increased with increasing age (p-trend < 0.001), 
and all measures of PA decreased with increasing age (p-trend < 0.001). 
3.1. Association between PA and LAVi 
In the overall sample, there was a significant trend towards 
increasing LAVi with increasing PA-quartiles in the fully adjusted Model 
2 (p-trend = 0.017, Table S1). Participants with the highest PA level 
(quartile 4) had larger LAVi (2.31 mL/m2, p = 0.015) than participants 
in quartile 1. LAVi increased non-significantly with increasing MVPA (p 
= 0.176) and steps (p = 0.184). 
We found significant interactions between PA*age, and between 
PA*diastolic function in the association between PA and LAVi. The as-
sociation between PA and LAVi showed a positive trend in age groups <
70 years (Fig. 1a-c), whereas no significant association between PA and 
LAVI among those aged ≥ 70. Furthermore, the association between PA 
and LAVi showed a positive trend in participants with normal diastolic 
function (Fig. 1d-f), but no significant association between PA and LAVi 
in participants with abnormal diastolic function. When both the in-
teractions between PA*age, and PA*diastolic function were added to the 
multiple adjusted Model 2 (Table S2), interactions between PA*age, and 
PA*diastolic function remained significant (p < 0.05). Therefore, 
further analyses were stratified by age and diastolic function. The as-
sociation between PA and LAVi showed a positive trend in participants 
< 70 years with normal diastolic function, whereas no significant as-
sociation was observed in participants ≥ 70 years or in participants with 
abnormal diastolic function (Fig. 2). 
When stratified by age (Table 2), both models showed positive as-
sociations between PA and LAVi in the age groups < 70 years. In those 
aged 40–54 years, LAVi increased by 0.62 mL/m2 for every 1000 steps 
per day increase (p = 0.002). In addition, there was a significant trend 
showing increased LAVi by increasing PA-quartiles (p-trend = 0.009). 
LAVi was significantly larger (4.45 mL/m2, p = 0.016) in participants in 
PA-quartile 4 vs. quartile 1. In participants aged 55–69 years, LAVi 
increased by 0.32 mL/m2 for every 10 min increase in MVPA per day (p 
= 0.021). There was also a significant trend showing increased LAVi by 
increasing PA-quartiles (p-trend = 0.007). LAVi was significantly larger 
(2.93 mL/m2, p = 0.020) in participants in PA-quartile 4 vs. quartile 1. 
There were no significant associations between PA and LAVi in partic-
ipants aged ≥ 70 years. 
Associations between PA and LAVi stratified by diastolic function 
showed increased LAVi by increasing PA-quartiles in participants with 
normal diastolic function (p-trend = 0.002) (Table 3). In participants 
with normal diastolic function, LAVi was significantly larger (2.77 mL/ 
m2, p = 0.002) in participants in PA-quartile 4 vs. quartile 1. Further-
more, LAVi increased by 0.22 mL/m2 for every 10 min increase in MVPA 
per day (p = 0.033), and by 0.29 mL/m2 for every 1000 steps per day 
increase (p = 0.009). There were no significant associations between PA 
and LAVi in participants with abnormal diastolic function. 
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In general, associations between PA-quartiles and LAVi stratified by 
hypertension, CVD, LV mass index or sex (Table S3-S6) showed rather 
similar results as when stratifying for diastolic function. No associations 
were observed when stratifying by BMI (Table S7). Furthermore, we 
explored the associations between PA and LAVi using an extended 
model (Model 3) adjusted for myocardial infarction, HF and valvular 
disorders in addition to Model 2. In general, we observed similar asso-
ciations between PA and LAVi as in Model 2, although, some of the as-
sociations were slightly stronger in Model 3. As for Model 2, we 
observed associations between PA and LAVi in participants < 70 years 
(Table S8), and in participants with normal diastolic function (Table S9). 
There were no associations between PA and LAVi in participants ≥ 70 
years or with abnormal diastolic function. 
3.2. Association between LAVi enlargement and indices of diastolic 
dysfunction 
LAVi enlargement was associated with unfavorable increase in E/ 
e’ratio (0.24, p < 0.001) and TRV (0.02 m/s, p < 0.001) for every mL/ 
m2 increase in the most inactive participants, whereas no associations 
were seen in higher PA-quartiles (Table S10). 
Fig. 1. a-c show adjusted mean LAVi stratified by age and PA, and Fig. 1d-f show adjusted mean LAVi stratified by LV diastolic function and PA. Fig. 1a and 1d show 
mean LAVi for the PA-quartiles, where quartile 1 is least active and quartile 4 most active. Fig. 1b and 1e show mean LAVi for every 10 min increase in MVPA per day, 
and Fig. 1c and 1f show mean LAVi for every 1000 steps per day increase. Mean values were adjusted for sex, BMI, systolic blood pressure, diabetes, smoking, and 
LDL cholesterol. LAVi: left atrial volume index, PA: physical activity, MVPA: moderate-to-vigorous physical activity, BMI: body mass index, LDL: low-density li-
poprotein. The Tromsø Study 2015–16. 
Fig. 2. Adjusted mean LAVi stratified by LV diastolic function, age and PA. Fig. 2a show mean LAVi for the PA-quartiles, where quartile 1 is least active and quartile 
4 most active. Fig. 2b show mean LAVi for every 10 min increase in MVPA per day, and Fig. 2c show mean LAVi for every 1000 steps per day increase. Mean values 
were adjusted for PA level, sex, BMI, systolic blood pressure, diabetes, smoking, and LDL cholesterol. LAVi: left atrial volume index, PA: physical activity, MVPA: 
moderate-to-vigorous physical activity, BMI: body mass index, LDL: low-density lipoprotein. The Tromsø Study 2015–16. 
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3.3. Sensitivity analysis 
When excluding participants with atrial fibrillation (AF, n = 44), we 
observed similar associations between PA and LAVi, and between LAVi 
enlargement and indices of diastolic dysfunction as the main results. 
Therefore, we included participants with AF in our analysis. 
4. Discussion 
To the best of our knowledge, this is the first study that examined the 
association between objectively measured PA and LAVi in the general 
adult and elderly population. Our main findings are that higher levels of 
PA are associated with greater LAVi, but only in participants < 70 years 
with normal diastolic function, and that LAVi enlargement is associated 
with indices of diastolic dysfunction only in the most inactive partici-
pants. Our results indicate that LAVi enlargement in physically active 
individuals is not an expression of cardiac dysfunction. 
4.1. PA and LA size 
When stratified by age and diastolic function in the same multivar-
iable model, we observed significant trends between PA and LAVi in age 
groups < 70 years with normal diastolic function only. These findings 
suggest that the relationship between higher age and increased LA size is 
mainly explained by diastolic function, as there was no difference be-
tween age groups when excluding those with diastolic dysfunction. 
Similar to our results, Joseph et al. (2019) reported that PA had 
greater impact on cardiac alterations in younger than older subjects in 
the general population. They reported that higher levels of PA improved 
both systolic and diastolic function (evaluated by longitudinal 
displacement, e’, and myocardial performance index) and lowered 
resting heart rate in participants ≤ 65 years, whereas there was no effect 
of PA in those > 65 years. Furthermore, the authors suggested that there 
is a cut-off point in age, where the beneficial effects of PA ceases. 
Table 2 
Associations between physical activity and left atrial volume index by age 





β (95% CI) 
Model 2 
β (95% CI) 
Age 40–54 
CPM 297 32.0 (9.0)   
PA-quartile 1 28 29.5 (6.6) 0.00 (Ref.) 0.00 (Ref.) 










PA-quartile 4 123 34.5 (8.1) 5.05 (1.46, 8.64) 4.45 (0.82, 8.08) 
p-trend   0.001 0.009 
MVPA per 10 min/ 
day 
297 32.0 (9.0) 0.41 (0.08, 0.74) 0.31 (-0.03, 
0.65) 
p-trend   0.015 0.074 
Steps per 1000/day 297 32.0 (9.0) 0.77 (0.40, 1.13) 0.62 (0.23, 1.00) 
p-trend   <0.001 0.002 
Age 55–69 
CPM 714 32.6 
(10.9)   
PA-quartile 1 131 31.7 
(12.3) 
0.00 (Ref.) 0.00 (Ref.) 
PA-quartile 2 184 31.4 
(10.0) 














2.93 (0.46, 5.41) 
p-trend   0.018 0.007 




0.33 (0.07, 0.60) 0.32 (0.05, 0.59) 
p-trend   0.015 0.021 






p-trend   0.110 0.081 
Age ≥ 70 
CPM 531 37.8 
(14.7)   
PA-quartile 1 224 37.7 
(15.4) 
0.00 (Ref.) 0.00 (Ref.) 






PA-quartile 3 110 37.5 
(15.1) 
− 0.19 (-3.57, 
3.19) 
− 0.23 (-3.67, 
3.22) 






p-trend   0.938 0.960 




− 0.26 (-0.76, 
0.24) 
− 0.30 (-0.82, 
0.23) 
p-trend   0.312 0.267 
Steps per 1000/day 531 37.8 
(14.7) 
− 0.21 (-0.72, 
0.30) 
− 0.24 (-0.78, 
0.29) 
p-trend   0.425 0.374 
LAVi: left atrial volume index, SD: standard deviation, CI: confidence interval, 
Ref.: reference, CPM: counts per minute, PA: physical activity, MVPA: moderate- 
to-vigorous physical activity, BMI: body mass index, LDL: low-density lipopro-
tein. 
Model 1 was unadjusted. Model 2 was adjusted for sex, BMI, systolic blood 
pressure, diabetes, smoking, and LDL cholesterol. 
Table 3 
Associations between physical activity and left atrial volume index by left 
ventricular diastolic function (unstandardized coefficients ± 95% CI). The 





β (95% CI) 
Model 2 
β (95% CI) 
Normal diastolic functiona 
CPM 1105 30.8 (9.4)   
PA-quartile 1 236 29.9 
(10.0) 
0.00 (Ref.) 0.00 (Ref.) 










PA-quartile 4 300 32.6 (8.3) 2.77 (1.17, 4.37) 2.77 (1.02, 4.51) 
p-trend   0.001 0.002 
MVPA per 10 min/ 
day 
1105 30.8 (9.4) 0.25 (0.06, 0.43) 0.22 (0.02, 0.42) 
p-trend   0.009 0.033 
Steps per 1000/day 1105 30.8 (9.4) 0.30 (0.11, 0.48) 0.29 (0.07, 0.50) 
p-trend   0.002 0.009 
Abnormal diastolic functionb 
CPM 437 43.0 
(14.3)   
PA-quartile 1 147 43.4 
(16.2) 
0.00 (Ref.) 0.00 (Ref.) 
PA-quartile 2 108 42.8 
(12.9) 
− 0.64 (-4.22, 
2.94) 
− 0.66 (-4.29, 
2.97) 
PA-quartile 3 96 42.8 
(14.7) 
− 0.59 (-4.29, 
3.12) 
− 0.36 (-4.16, 
3.44) 
PA-quartile 4 86 42.8 
(12.2) 
− 0.67 (-4.50, 
3.17) 
− 0.79 (-4.85, 
3.27) 
p-trend   0.721 0.735 






− 0.02 (-0.52, 
0.48) 
p-trend   0.925 0.928 
Steps per 1000/day 437 43.0 
(14.3) 
− 0.14 (-0.60, 
0.33) 
− 0.18 (-0.70, 
0.34) 
p-trend   0.567 0.490 
LAVi: left atrial volume index, SD: standard deviation, CI: confidence interval, 
Ref.: reference, CPM: counts per minute, PA: physical activity, MVPA: moderate- 
to-vigorous physical activity, BMI: body mass index, LDL: low-density lipopro-
tein. 
Model 1 was unadjusted. Model 2 was adjusted for age, sex, BMI, systolic blood 
pressure, diabetes, smoking, and LDL cholesterol. 
a Normal diastolic function = <50% positive variables. 
b Abnormal diastolic function = ≥50% positive variables. 
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The positive association between PA and LAVi observed in our study 
is widely supported by previous studies on athletes (Iskandar et al., 
2015; Pelliccia et al., 2005). In addition, the association between exer-
cise and LAVi has been demonstrated in adolescent endurance athletes 
(Hoogsteen et al., 2003). In the general adult population, the association 
between cardiorespiratory fitness and LAVi (Letnes et al., 2020), and the 
association between objectively measured PA and LA dimension has 
been demonstrated (Andersson et al., 2015). Furthermore, the rela-
tionship between exercise and LAVi has also been confirmed in a ran-
domized controlled trial with middle-aged adults (Opondo et al., 2018). 
In contrast to our results, Bjerring et al. (2018) found no association 
between exercise and LAVi although they observed other associations 
between exercise and cardiac remodelling in preadolescent athletes. The 
lack of significant association between exercise and LAVi may be due to 
the participants’ young age, and because atrial remodelling depends on 
years of training (D’Andrea et al., 2010). 
Enlarged LAVi is considered a normal physiological adaptation to 
exercise in athletes, and it is well documented that the cardiac chambers 
increase by exercise (Iskandar et al., 2015; Pelliccia et al., 2005). 
Enlarged chambers and the accompanying capability to generate a large 
stroke volume are the main alterations by exercise-induced cardiac 
remodelling (Weiner and Baggish, 2012), and a large stroke volume is 
essential for athletic endurance and performance (Bassett and Howley, 
2000). Our results indicate that the exercise-induced cardiac adapta-
tions start at lower levels of PA than the typical training load of an 
athlete, and that exercise-induced LA remodelling also affects the gen-
eral and elderly population. 
In athletes, it has been demonstrated that LA enlargement is not 
necessarily associated with LA dysfunction (D’Ascenzi et al., 2011). In 
fact, supernormal LV diastolic function has been documented in athletes 
with LA enlargement (D’Ascenzi et al., 2011). These athletes typically 
have normal reservoir function and reduced LA active contraction 
(D’Ascenzi et al., 2018). Reduced LA active contraction represents a 
more efficient filling of the heart, due to larger contribution from passive 
hemodynamic instead of active contractions (Lakatos et al., 2020). 
These documented improvements in LA function supports our results 
that LAVi enlargement in physically active individuals is benign. 
The physiological mechanisms triggering LA remodelling in athletes 
are the increased hemodynamic stress on the walls due to increased 
stroke volume and cardiac output during exercise (D’Ascenzi et al., 
2018). In contrast, LA enlargement may also reflect the presence of LA 
dysfunction and increased filling pressures over time (D’Ascenzi et al., 
2020; Nagueh et al., 2016). Furthermore, LA enlargement is seen in 
subjects with AF and valvular disease (Nagueh et al., 2016). However, in 
our study population only a few participants had AF, and sensitivity 
analysis revealed that the associations between PA and LAVi were 
almost unchanged if they were included or not. Also, adjustment for 
valvular disease and HF did not change the associations between PA and 
LAVi. This suggests that enlarged LAVi with increasing levels of PA is 
due to exercise-induced LA remodelling. 
4.2. LA enlargement and indices of diastolic dysfunction 
We observed an association between LAVi enlargement and 
increased E/e’ratio and TRV among the most inactive participants only. 
This finding is of importance as increased E/e’ratio is associated with 
CVD, all-cause mortality and HF (Mitter et al., 2017). Also, elevated TRV 
indicates elevated LV filling pressure, and is a main criteria for deter-
mining LV diastolic dysfunction (Nagueh et al., 2016). However, as 
mean TRV was 1.8 m/s in the most inactive participants, the insuffi-
ciency was well within the border of a normal TRV (Nagueh et al., 
2016). 
Our results are supported by previous literature which have 
demonstrated lower E/e’ratio with higher levels of PA (D’Ascenzi et al., 
2011), and that older participants reporting ideal levels of PA have 
lower E/e’ratio compared to those who reported low PA (Hegde et al., 
2016). Furthermore, it has been demonstrated that low cardiorespira-
tory fitness is associated with higher E/e’ratio, compared with higher 
levels of fitness (Brinker et al., 2014). In contrast, some researchers have 
reported no association between LAVi and E/e’ratio or TRV (Letnes 
et al., 2020), or between PA and E/e’ratio (Andersson et al., 2015) in 
healthy adults or middle-aged. This discrepancy may be explained by a 
younger and healthier population in these studies. It is suggested that 
the age-related changes in diastolic function are probably not developed 
in young cohorts (Hegde et al., 2016). 
Furthermore, LA enlargement is an independent risk factor for AF in 
the general population (Pelliccia et al., 2005). Although it is well 
documented that moderate levels of PA decreases the risk of AF 
(Valenzuela et al., 2020), vigorous endurance exercise may be associ-
ated with increased risk of AF (D’Ascenzi et al., 2015). However, solid 
evidence for exercise-induced LA enlargement as a substrate for AF is 
lacking (D’Ascenzi et al., 2015). Furthermore, in a large study of 1800 
competitive athletes, the authors demonstrated frequently LA enlarge-
ment, but low prevalence of AF (<1%) (Pelliccia et al., 2005). 
4.3. Strengths and limitations 
The main strength of this study is the combined use of objectively 
measured PA and echocardiography in a large study population with a 
wide age span. Our large study population of adult and elderly in-
dividuals represents the general population. Self-reported PA is prone to 
both recall- and social desirability bias (Prince et al., 2008), and is 
neither able to capture light PA or assess MVPA precisely (The 2018 
Physical Activity Guidelines Advisory Committee, 2018). In contrast, 
device based measured PA provides objective and more valid data across 
the whole spectrum of PA as well as total accumulated PA throughout 
the day (Chomistek et al., 2017). The echocardiography was conducted 
according to current guidelines, and we used the recommended LAVi 
calculated with the Simpson’s biplane method to assess LA size (Lang 
et al., 2015). 
Potential limitations should be addressed. Firstly, the cross-sectional 
study design prevents evaluation of longitudinal changes in PA and LA 
size, or intra-subject LA remodelling, and we cannot establish direction 
of the association or causation. Secondly, lack of data on LA function 
prevents extensive evaluation of the association between PA and LA 
remodelling. Thirdly, lack of data from cardiopulmonary exercise- 
testing prevents us from evaluating the impact of cardiorespiratory 
fitness on LA remodelling. Fourthly, although we adjusted for cova-
riates, we cannot exclude the possibility of residual confounding. Fifth, 
due to few participants with diastolic dysfunction, diastolic function was 
dichotomized into normal or abnormal. This may have underestimated 
the influence of diastolic dysfunction on LAVi, as the indeterminate 
cases (=50% positive variables) were defined as abnormal. Lastly, as the 
accelerometer fails to register water-based activities and is less accurate 
in movements involving small trunk motions (e.g. bicycling), the par-
ticipant’s true PA is probably somewhat underestimated. 
In conclusion, increasing level of PA was associated with greater 
LAVi in the general adult and elderly population < 70 years with normal 
LV diastolic function, whereas no associations were seen at ages ≥ 70 
years or for participants with abnormal diastolic function. Furthermore, 
LAVi enlargement was only associated with diastolic dysfunction in the 
most inactive PA-quartile. The beneficial effect of PA on indices of LV 
diastolic dysfunction was observed from PA-quartile 2, with no addi-
tional benefits from increasing PA. 
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